Enhanced growth of pancreatic tumors in SPARC-null mice is associated with decreased deposition of extracellular matrix and reduced tumor cell apoptosis

Pauli A. Puolakkainen, Rolf A. Brekken, Sabeeha Muneer, E. Helene Sage

Research output: Contribution to journalArticle

114 Citations (Scopus)

Abstract

SPARC, a matricellular glycoprotein, modulates cellular interaction with the extracellular matrix (ECM). Tumor growth and metastasis occur in the context of the ECM, the levels and deposition of which are controlled in part by SPARC. Tumor-derived SPARC is reported to stimulate or retard tumor progression depending on the tumor type, whereas the function of host-derived SPARC in tumorigenesis has not been explored fully. To evaluate the function of endogenous SPARC, we have examined the growth of pancreatic tumors in SPARC-null (SP-/-) mice and their wild-type (SP+/+) counterparts. Mouse pancreatic adenocarcinoma cells injected s.c. grew significantly faster in SP-/- mice than cells injected into SP+/+ animals, with mean tumor weights at sacrifice of 0.415 ± 0.08 and 0.086 ± 0.03 g (P < 0.01), respectively. Lack of endogenous SPARC resulted in decreased collagen deposition and fiber formation, alterations in the distribution of tumor-infiltrating macrophages, and decreased tumor cell apoptosis. There was no difference in microvessel density of tumors from SP-/- of SP +/+ mice. However, tumors grown in SP-/- had a lower percentage of blood vessels that expressed smooth muscle α-actin, a marker of pericytes. These data reflect the importance of ECM deposition in regulating tumor growth and demonstrate that host-derived SPARC is a critical factor in the response of host tissue to tumorigenesis.

Original languageEnglish (US)
Pages (from-to)215-224
Number of pages10
JournalMolecular Cancer Research
Volume2
Issue number4
StatePublished - Apr 2004

Fingerprint

Extracellular Matrix
Apoptosis
Growth
Neoplasms
Carcinogenesis
Null Lymphocytes
Pericytes
Microvessels
Tumor Burden
Smooth Muscle
Blood Vessels
Actins
Glycoproteins
Adenocarcinoma
Collagen
Macrophages
Neoplasm Metastasis

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research

Cite this

Enhanced growth of pancreatic tumors in SPARC-null mice is associated with decreased deposition of extracellular matrix and reduced tumor cell apoptosis. / Puolakkainen, Pauli A.; Brekken, Rolf A.; Muneer, Sabeeha; Sage, E. Helene.

In: Molecular Cancer Research, Vol. 2, No. 4, 04.2004, p. 215-224.

Research output: Contribution to journalArticle

@article{bfbd7d071aed408782b659dfb4c02523,
title = "Enhanced growth of pancreatic tumors in SPARC-null mice is associated with decreased deposition of extracellular matrix and reduced tumor cell apoptosis",
abstract = "SPARC, a matricellular glycoprotein, modulates cellular interaction with the extracellular matrix (ECM). Tumor growth and metastasis occur in the context of the ECM, the levels and deposition of which are controlled in part by SPARC. Tumor-derived SPARC is reported to stimulate or retard tumor progression depending on the tumor type, whereas the function of host-derived SPARC in tumorigenesis has not been explored fully. To evaluate the function of endogenous SPARC, we have examined the growth of pancreatic tumors in SPARC-null (SP-/-) mice and their wild-type (SP+/+) counterparts. Mouse pancreatic adenocarcinoma cells injected s.c. grew significantly faster in SP-/- mice than cells injected into SP+/+ animals, with mean tumor weights at sacrifice of 0.415 ± 0.08 and 0.086 ± 0.03 g (P < 0.01), respectively. Lack of endogenous SPARC resulted in decreased collagen deposition and fiber formation, alterations in the distribution of tumor-infiltrating macrophages, and decreased tumor cell apoptosis. There was no difference in microvessel density of tumors from SP-/- of SP +/+ mice. However, tumors grown in SP-/- had a lower percentage of blood vessels that expressed smooth muscle α-actin, a marker of pericytes. These data reflect the importance of ECM deposition in regulating tumor growth and demonstrate that host-derived SPARC is a critical factor in the response of host tissue to tumorigenesis.",
author = "Puolakkainen, {Pauli A.} and Brekken, {Rolf A.} and Sabeeha Muneer and Sage, {E. Helene}",
year = "2004",
month = "4",
language = "English (US)",
volume = "2",
pages = "215--224",
journal = "Molecular Cancer Research",
issn = "1541-7786",
publisher = "American Association for Cancer Research Inc.",
number = "4",

}

TY - JOUR

T1 - Enhanced growth of pancreatic tumors in SPARC-null mice is associated with decreased deposition of extracellular matrix and reduced tumor cell apoptosis

AU - Puolakkainen, Pauli A.

AU - Brekken, Rolf A.

AU - Muneer, Sabeeha

AU - Sage, E. Helene

PY - 2004/4

Y1 - 2004/4

N2 - SPARC, a matricellular glycoprotein, modulates cellular interaction with the extracellular matrix (ECM). Tumor growth and metastasis occur in the context of the ECM, the levels and deposition of which are controlled in part by SPARC. Tumor-derived SPARC is reported to stimulate or retard tumor progression depending on the tumor type, whereas the function of host-derived SPARC in tumorigenesis has not been explored fully. To evaluate the function of endogenous SPARC, we have examined the growth of pancreatic tumors in SPARC-null (SP-/-) mice and their wild-type (SP+/+) counterparts. Mouse pancreatic adenocarcinoma cells injected s.c. grew significantly faster in SP-/- mice than cells injected into SP+/+ animals, with mean tumor weights at sacrifice of 0.415 ± 0.08 and 0.086 ± 0.03 g (P < 0.01), respectively. Lack of endogenous SPARC resulted in decreased collagen deposition and fiber formation, alterations in the distribution of tumor-infiltrating macrophages, and decreased tumor cell apoptosis. There was no difference in microvessel density of tumors from SP-/- of SP +/+ mice. However, tumors grown in SP-/- had a lower percentage of blood vessels that expressed smooth muscle α-actin, a marker of pericytes. These data reflect the importance of ECM deposition in regulating tumor growth and demonstrate that host-derived SPARC is a critical factor in the response of host tissue to tumorigenesis.

AB - SPARC, a matricellular glycoprotein, modulates cellular interaction with the extracellular matrix (ECM). Tumor growth and metastasis occur in the context of the ECM, the levels and deposition of which are controlled in part by SPARC. Tumor-derived SPARC is reported to stimulate or retard tumor progression depending on the tumor type, whereas the function of host-derived SPARC in tumorigenesis has not been explored fully. To evaluate the function of endogenous SPARC, we have examined the growth of pancreatic tumors in SPARC-null (SP-/-) mice and their wild-type (SP+/+) counterparts. Mouse pancreatic adenocarcinoma cells injected s.c. grew significantly faster in SP-/- mice than cells injected into SP+/+ animals, with mean tumor weights at sacrifice of 0.415 ± 0.08 and 0.086 ± 0.03 g (P < 0.01), respectively. Lack of endogenous SPARC resulted in decreased collagen deposition and fiber formation, alterations in the distribution of tumor-infiltrating macrophages, and decreased tumor cell apoptosis. There was no difference in microvessel density of tumors from SP-/- of SP +/+ mice. However, tumors grown in SP-/- had a lower percentage of blood vessels that expressed smooth muscle α-actin, a marker of pericytes. These data reflect the importance of ECM deposition in regulating tumor growth and demonstrate that host-derived SPARC is a critical factor in the response of host tissue to tumorigenesis.

UR - http://www.scopus.com/inward/record.url?scp=3543090480&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3543090480&partnerID=8YFLogxK

M3 - Article

VL - 2

SP - 215

EP - 224

JO - Molecular Cancer Research

JF - Molecular Cancer Research

SN - 1541-7786

IS - 4

ER -